AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells

Researchers look into At-Rich Interactive Domain 1A (ARID1A), which is frequently mutated in gastric cancers with poor prognosis, finding AKT inhibition might be an effective treatment for ARID1A deficient cells.